Norden Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Buy
14,531
+2,362
+19% +$211K 0.12% 163
2025
Q4
$962K Sell
12,169
-76,326
-86% -$5.98M 0.09% 199
2025
Q3
$7.07M Buy
88,495
+81,359
+1,140% +$6.94M 0.72% 26
2025
Q2
$649K Buy
7,136
+1,364
+24% +$125K 0.07% 280
2025
Q1
$541K Sell
5,772
-1,415
-20% -$127K 0.06% 295
2024
Q4
$653K Sell
7,187
-36,508
-84% -$3.48M 0.07% 283
2024
Q3
$4.54M Buy
+43,695
New +$4.45M 0.54% 44

Other funds holding CL

Norden Group's CL Position: Q1 2026 in Review

Norden Group increased its Colgate-Palmolive (CL) stake by 19% in Q1 2026, buying an estimated $211K and bringing the position to 14,531 shares worth $1.24M. The position accounts for 0.12% of the portfolio, ranked #163.

Norden Group first reported a position in CL in Q3 2024 and has held it in 7 quarters since. The position peaked at $7.07M in Q3 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Norden Group held 14,531 shares of Colgate-Palmolive worth $1.24M as of Q1 2026.
  • Norden Group bought 2,362 Colgate-Palmolive shares in Q1 2026, an estimated $211K.
  • Colgate-Palmolive made up 0.12% of Norden Group's portfolio in Q1 2026, its #163 holding.
  • Norden Group first reported a position in Colgate-Palmolive in Q3 2024 and has held it in 7 quarters since.
  • Norden Group's Colgate-Palmolive position peaked at $7.07M in Q3 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Norden Group's 13F filing for Q1 2026, filed 15 Apr 2026.